RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse

Histochemistry and Cell Biology

Volumn 117, Issue 3, 2002, Pages 283-292

  Mori, Hiroyuki ^a   Kitazawa, Riko ^a   Mizuki, Shinichi ^b   Nose, Masato ^b   Maeda, Sakan ^a   Kitazawa, Sohei ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

In situ hybridization; Osteoclast; RANKL; Rheumatoid arthritis; Synovia

Indexed keywords

COLLAGEN TYPE 2; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN; PROTEIN RANK; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BONE DESTRUCTION; CELL MATURATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROBLAST; IN SITU HYBRIDIZATION; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PANNUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BLOTTING, NORTHERN; BONE AND BONES; CARRIER PROTEINS; CELL LINE; COLLAGEN TYPE II; GENE EXPRESSION; GLYCOPROTEINS; HINDLIMB; IN SITU HYBRIDIZATION; JOINTS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED DBA; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TIBIA;

ANIMALIA;

EID: 0036207011     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-001-0376-9     Document Type: Article

References (37)

1. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic cell function
2. Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion
3. Increased mRNA expression and protein secretion of interleukin-6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone
4. Immunisation against heterologous type II collagen induces arthritis in mice
5. Role of cytokines in rheumatoid arthritis
6. Rheumatoid arthritis
7. Pathogenesis of bone erosions in rheumatoid arthritis
8. Cellular mechanism and the role of cytokines in bone erosions in rheumatoid arthritis
9. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis
10. Activated T lymphocytes support osteoclast formation in vitro
11. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
12. Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent
13. Interleukin-4 induces expression of the integrin αvβ3 via transactivation of the β3 gene
14. In situ hybridization with polymerase chain reaction-derived single-stranded DNA probe and S1 nuclease
15. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
16. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
17. Mechanism of tissue destruction in rheumatoid arthritis
18. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
19. The erosive front: A topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head
20. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA)
21. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
22. Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis: A therapeutic study using a macrophage-deactivating compound
23. Assessment of phalangeal bone loss in patients with rheumatoid arthritis by quantitative ultrasound
24. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis
25. Expression of osteoclast differentiation factor in rheumatoid arthritis
26. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
27. Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus
28. Modulation of osteoclast differentiation
29. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
30. A new member of tumor necrosis factor ligand family. ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function
31. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
32. Bone resorption by osteoclasts
33. Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression
34. Autoimmunity to type II collagen an experimental model of arthritis
35. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?
36. The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor
37. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL